Depuis leur introduction, les agents de contraste ont révolutionné l'imagerie échographique. Ils sont composés de microbulles gazeuses, qui injectés par voie intraveineuse dans le sang, ils améliorent l'image échographique. Une autre application pour laquelle les caractéristiques physiques des agents de contraste sont exploitées est l'imagerie ciblée. Une approche basée sur l'utilisation de ligands intégrés à la paroi des microbulles, celles-ci adhérent aux facteurs de surfaces moléculaires surexprimés par les cellules endothéliales qui tapissent la paroi interne des vaisseaux sanguins. Pour pouvoir distinguer ces microbulles de celles qui circulent librement, elles doivent réfléchir un signal acoustique suffisamment intense. Cependant, le faible taux d'adhérence des microbulles engendre une réduction du signal acoustique. Pour résoudre ce problème, il est important de déterminer l'effet des parois sur leurs dynamiques acoustiques. Dans cette thèse, nous avons étudié l’effet des parois élastiques sur le comportement dynamique des microbulles constituant les agents de contraste. Dans un premier temps, un modèle théorique représentant une paroi avec une épaisseur finie a été développé. Il a été démontré que l’amplitude de l’écho rétrodiffusé par une microbulle proche d’une paroi avec une épaisseur finie est inférieure à celui d’une microbulle se trouvant dans un fluide infini. D'autres parts, pour représenter la paroi d’un vaisseau sanguin, les propriétés mécaniques de la paroi élastique ont été intégrées au modèle. Il a été observé que la fréquence de résonance d’une microbulle proche d’une paroi est supérieure à celle dans un fluide infini. Par la suite, nous avons étudié l’effet de trois types de parois sur le comportement d’une microbulle parmi lesquelles la paroi d'OptiCell communément utilisée en expérimentations ultrasonores. Les résultats ont montré que la microbulle proche de la paroi d’OptiCell diffuse un écho supérieur à celui de la microbulle éloignée de la paroi, lorsque la fréquence d’excitation est au-dessus de sa fréquence de résonance. Nous avons constaté aussi que les petites bulles sont plus sensibles à la proximité de la paroi. Par la suite, nous avons développé un modèle décrivant une microbulle attachée à une paroi élastique. Nous avons montré que le contact direct de la bulle avec la paroi induit une diminution de l'écho par rapport à la même bulle dans un liquide infini. Le contact direct de la bulle avec la paroi engendre une augmentation de la fréquence de résonance part rapport à une bulle sans contact direct. Enfin, une étude expérimentale a montré l'avantage de l'imagerie sous-harmonique pour différencier les microbulles attachées des microbulles libres. / Since they were introducted, contrast agents have revolutionized the ultrasound imaging. They are composed of tiny gaseous microbubbles and when injected intravenously into the blood, they improve the ultrasound image. Targeted imaging is another application based on the physical characteristics of contrast agents. This approach is based on the ligands incorporation into the microbubbles shell. The microbubble attach to the molecular factors overexpressed by endothelial cells, covering the inner wall of blood vessels. To distinguish these microbubbles from those freely circulating, attached microbubble have to produce an acoustic signal that is sufficiently strong. However, the low microbubbles adhesion induces a decrease of the acoustic signal. To make it possible, it is important to determine the effect of the elastic wall on their acoustic response. This thesis aimed to study the effect of elastic walls on the ultrasonic behavior of targeted microbubbles. First, a theoretical model describing a wall with finite thickness was developed. It has been shown that the scattered echo amplitude by a microbubble near a wall with finite thickness is small in comparison to the echo from a microbubble located in an infinite fluid. Furthermore, and in order to account for the effect of blood vessel wall, the mechanical properties of the wall have been incorporated into the model. The results showed that the resonane frequency of a microbubble near the wall is higher than the resonanace of the same microbubble in an infinite medium. Subsequently, we studied the effect of three types of walls on the microbubble behavior including the wall of OptiCell chamber which is commonly used in ultrasonic experiments. We have shown that microbubbles near the OptiCell wall diffuses a higher echo than those far from the wall when the excitation frequency is above the microbubble resonance frequency. On the other side, we observed that small microbubbles to the presence of the wall. Afterward, we developed a model describing a microbubble attached to the wall. We have shown that the microbubble in direct contact with the wall induces a decrease of the echo amplitude compared to the same bubble in infinite liquid. Moreover, the direct contact of the bubble with the wall generates an increase of the resonance frequency relative to a bubble without direct contact. Finally, an experimental study has shown the advantage of the subharmonic imaging to differentiate attached microbubbles from the free ones.

Dans la foulée des avancées en médecine nucléaire, l’imagerie moléculaire par résonance magnétique a pris son essor ces dernières années car elle constitue un enjeu contemporain en vue d’améliorer le diagnostic et le suivi thérapeutique de pathologies comme le cancer ou la maladie d’Alzheimer. Cependant, cette technique d’imagerie médicale souffre à la fois de la petite quantité de récepteurs disponibles in vivo et de la faible sensibilité de l’IRM pour la détection d’agents de contraste exogènes. De ce fait, la littérature montre un intérêt croissant pour le développement de nouveaux agents de contraste pouvant porter plusieurs milliers de contrastophores et de nouvelles techniques sont nécessaires pour évaluer l’efficacité de ces derniers. Ainsi, lorsqu’un agent de contraste fonctionnalisé est injecté in vivo, ce dernier va subir de nombreux processus biochimiques (extravasation, fixation spécifique sur les récepteurs, internalisation dans les cellules…) qui peuvent rendre les mécanismes de prise de contraste difficile à appréhender. De ce fait, nous avons développé une nouvelle méthode in vitro d’observation cellulaire permettant de caractériser les agents de contraste par IRM en modélisant expérimentalement certains des mécanismes ayant lieu in vivo, tout en s’affranchissant des problèmes liées à l’expérimentation sur petit animal (résolution, Rapport signal sur bruit, reproductibilité inter-animale,…). Notre approche a reposé sur la conception d’un dispositif de microhistologie par IRM qui permet de détecter une monocouche de cellules d’une dizaine de microns d’épaisseur dans un environnement microfluidique. Après avoir totalement caractérisé notre méthode avec des cellules ayant internalisé un agent de contraste commercial (Dotarem), nous l’avons utilisé pour évaluer la capture dynamique d’un nouvel agent de contraste développé à Guerbet : une émulsion paramagnétique fonctionnalisée avec des peptides RGD destinée à l’imagerie de l’angiogénèse tumorale. Dans un canal microfluidique, nous avons préparé une monocouche confluente de cellules endothéliales et appliqué un flux d’agent de contraste au-dessus de ces dernières. Par IRM, nous avons pu réaliser un suivi dynamique de la capture de l’agent de contraste par les récepteurs membranaires des cellules. En plus de démontrer la spécificité de l’agent de contraste comme le font les méthodes traditionnelles, notre technique nous a permis d’évaluer les constante cinétiques d’association et de dissociation et la constante d’affinité de l’agent de contraste pour les récepteurs dans des conditions physiologiques proches de celles existant in vivo, notamment en termes de disposition des cellules et de la vitesse et de la concentration de l’agent de contraste. / Following the recent advances in nuclear medicine, magnetic resonance imaging has rapidly become an emerging technique for molecular imaging since it constitutes a contemporary issue for the improvement of the diagnosis and the post-treatment follow-up of pathologies such as cancer and Alzheimer’s disease. However, this technique suffers from both the weak amount of in vivo receptors and the low sensitivity of MRI for the detection of exogenous contrast agents. Thus, the literature shows an increasing interest for the development of novel contrast agents which can carry several thousands of contrastophores and new techniques are needed to evaluate the efficiency of these contrast agents. Indeed, when a targeted contrast agent is injected intraveneously, many biochemical process can occur simultaneously (extravasation, specific binding on receptors, internalization inside cells, …), which can make the contrast uptake mechanisms difficult to investigate. Hence, we developed a new method of cellular observation allowing to characterize the contrast agent by MRI, by imitating some of the in vitro mechanisms that occur in vivo. Using this technique, we also avoided problems that are linked to the experimentation on small animal in terms of resolution, signal to noise ratio and inter-animal reproducibility.Our approach was based on the design and fabrication of a microhistological device that allows to detect a living cells’ monolayer - whose thickness is above 10 microns - in a microfluidic environment. After having fully characterized our method with cells that had internalized a commercial contrast agent (Dotarem), we used it to evaluate the dynamic uptake of a new contrast agent developed and synthetized in Guerbet : a paramagnetic nanoemulsion functionalized with RGD peptides to target the avb3 integrins that play a capital role in the tumor angiogenesis process. In a microfluidic channel, we prepared an endothelial cell monolayer and applied a flow of contrast agent over the cell layer. We were able to follow-up by MRI the uptake of the contrast agent by the cell surface receptors. Besides demonstrating the specificity of the contrast agent as well as traditional in vitro techniques, our technique provides an additional information level since it is able to evaluate the kinetic constants and the affinity of the contrast agents toward the receptors. These experiments were done under physiological conditions close to the ones existing in vivo in terms of cell arrangement, concentration and flow velocity of the contrast agent.

Submitted by PPG Engenharia e Tecnologia de Materiais (engenharia.pg.materiais@pucrs.br) on 2018-05-17T18:27:28Z No. of bitstreams: 1 Tese - Elisa Magno Nunes de Oliveira.pdf: 7318970 bytes, checksum: a50f399a4afea119cd760c93cd71ff72 (MD5) / Approved for entry into archive by Sheila Dias (sheila.dias@pucrs.br) on 2018-05-23T14:59:14Z (GMT) No. of bitstreams: 1 Tese - Elisa Magno Nunes de Oliveira.pdf: 7318970 bytes, checksum: a50f399a4afea119cd760c93cd71ff72 (MD5) / Made available in DSpace on 2018-05-23T15:10:26Z (GMT). No. of bitstreams: 1 Tese - Elisa Magno Nunes de Oliveira.pdf: 7318970 bytes, checksum: a50f399a4afea119cd760c93cd71ff72 (MD5) Previous issue date: 2018-03-20 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior - CAPES / The present study focuses on the development of nanoparticles with an iron oxide magnetic core, with different biocompatible coatings, and on a comparative study of their toxicities. Uncoated and dextran-, chitosan-, polyethylene glycol- and silica-coated nanoparticles were synthesized. The addition of optical markers of the benzo-thiazoles class was also accomplished. The physico-chemical properties of the nano-particles were characterized, including their magnetic, optical and contrast properties in nuclear magnetic resonance imaging (relaxivities). In the particular case of nanopar-ticles functionalized with 6-OH-BTA-1 molecules, the affinity to the beta-amyloid pep-tide was also investigated. A second step was to evaluate the toxicological effects of these nanoparticles in vitro (using in VERO cells), and in vivo with zebrafish as an animal model. The size of the nanoparticles with the coatings ranged from 13 to 30 nm. Their crystalline structure was consistent with the ferrite spinel. The nanoparticles, independent of the coating, did not present residual magnetization and hysteresis, in-dicating superparamagnetic behaviour. For most nanoparticles, the r2 transverse re-laxivity values ranged from 76-64 mM-1.s-1, exceptfor uncoated and chitosan-coated nanoparticles, which present higher values, possibly due to the aggregation. The val-ues of r1 were similar for all nanoparticles (12.6 to 18 mM-1.s-1), with the exception of silica-coated nanoparticles (r1=2.1 mM-1.s-1). The r2/r1 ratios were between 4 and 17, typical of commercially available negative contrast-agents. The nanoparticles function-alized with benzothiazoles showed fluorescence with a Stokes shift of the emission peak of ~ 197 nm. The interaction of the beta-amyloid peptide with the 6-OH-BTA-1 molecule analyzed by fluorescence suppression is characterized by a static mecha-nism and Stern-Volmer constants of 1.53x104 mM-1 for the monomeric form, 1.40x104 mM -1 for oligomers) and 1.33x104 mM -1 for amyloid plaques.The in vitro toxicity assays indicated acceptable values of cell viability for iron concentration up to 2 mmol.L-1. The nanoparticles with the carboxysilane and polyethylene glycol showed higher biocom-patibility and silica-coated nanoparticles had the highest cytotoxicity. The in vivo as-says did not show significant changes in survival and hatchability rates, except for doses greater than 2 mmol.L-1 in the case of the chitosan-coated nanoparticles. The percentages of animals with anatomical alterations were similar between the treated and control groups. In the locomotion and exploration tests, only chitosan- and silica-coated nanoparticles induced significant changes. / O presente trabalho aborda o desenvolvimento de nanopart?culas compostas por um n?cleo magn?tico de ?xido de ferro com diferentes revestimentos biocompat?-veis e estudo comparativo de suas toxicidades. Foram sintetizadas nanopart?culas de ?xido de ferro sem revestimento e com revestimentos de dextrana, quitosana, polieti-lenoglicol e s?lica, e com a adi??o de marcadores ?pticos da classe dos benzotiaz?is. As propriedades f?sico-qu?micas das nanopart?culas foram caracterizadas, incluindo as suas propriedades magn?ticas, ?pticas e de contraste em imagens por resson?ncia magn?tica nuclear (relaxividades), bem como a afinidade ao pept?deo beta-amiloide, no caso particular de funcionaliza??o com a mol?cula 6-OH-BTA-1. Em uma segunda etapa, foram avaliados os efeitos toxicol?gicos dessas nanopart?culas em ensaios bi-ol?gicos in vitro em c?lulas VERO, e in vivo tendo como animal modelo o peixe zebra. O tamanho das nanopart?culas com revestimentos variou entre 13 a 30 nm, e estrutura cristalina coerente com o espin?lio de ferrita. As nanopart?culas n?o apresentaram magnetiza??o residual e histerese, indicando superparamagnetismo, independente do revestimento. Para a maioria das nanopart?culas, os valores de relaxividade transver-sal r2 variaram de 76-64 mM-1.s-1, com exce??o das nanopart?culas sem revestimento e de quitosana, os quais foram mais elevados, possivelmente devido ao efeito de agrega??o. Os valores de r1 foram semelhantes para todas as nanopart?culas (12,6 a 18 mM-1.s-1), com exce??o das nanopart?culas de s?lica (r1 = 2,1 mM-1.s-1). As raz?es r2/r1 foram entre 4 e 17, valores t?picos de agentes de contraste negativos comercial-mente dispon?veis. As nanopart?culas funcionalizadas com os benzotiaz?is mantive-ram sua fluoresc?ncia com deslocamentos de Stokes na ordem de 197 nm para o pico de emiss?o. As an?lises da intera??o do pept?deo beta-amiloide com a mol?cula 6-OH-BTA-1, mostraram valores de constante de Stern-Volmer para supress?o de fluo-resc?ncia de 1,53x104 mM-1 (mon?mero), 1,40x104 mM-1 (olig?mero) e 1,33x104 mM-1 (placa), indicando quenching por um mecanismo est?tico. O pept?deo na forma mo-nom?rica demonstrou maior facilidade de acesso ?s mol?culas de 6-OH-BTA-1. Os resultados dos ensaios in vitro indicaram valores aceit?veis de viabilidade celular para concentra??o de ferro inferior a 2 mmol.L-1. As nanopart?culas com o carboxisilano e polietilenoglicol demostraram maior biocompatibilidade e as nanopart?culas de s?lica tiveram a maior citotoxicidade. Os resultados dos ensaios in vivo n?o mostraram alte-ra??es significativas na taxa de sobreviv?ncia e de eclos?o do corium, exceto para as doses maiores que 2 mmol.L-1 das nanopart?culas revestidas com quitosana. Os per-centuais de animais com altera??es anat?micas foram similares entre os grupos tra-tados e de controle. Nos ensaios de locomo??o e explora??o, apenas as nanopart?cu-las de quitosana e de s?lica induziram altera??es adversas significativas.

<p>To optimize contrast agent in MRI scan region, e.g. to enhance paramagnetic relaxation in the MRI scan fields(0.1T-3T), one possible way is to slow down the tumbling of the paramagnetic complex. The effect of slowing down the reorientational motion of the complex to increase relaxivity is obvious and this strategy has already been employed in producing MRI contrast agent that can bind to specific proteins. An example is MS-325 binds to human serum albumin(HSA). The slow down effects on the ligands around paramagnetic ion, and on the zero field splitting(ZFS) interaction are under studies and the physics behind is still not clear. In this thesis, a generalized Solomon-Bloembergen-Morgan(GSBM) theory together with stochastic Liouville approach(SLA), is applied to investigate the mechanism behind the slow down effects. Two gadolinium complexes, MS-325+HSA and Gd(H₂O)₈³⁺+glycerol are studied by means of NMRD and ESR experiments.</p><p>GSBM is a second order perturbation theory with closed analytical form. The computation based on this theory is fast, but it has its limitation and in the case of Gd(S=7/2) the ZFS strength times its correlation time(Δ<i>t</i>.<i>τ</i>_ƒ) should be less than 0.1. In comparison, the SLA is an "exact" theory that can evaluate the validity of GSBM calculation. However, the calculation in SLA is time consuming due to the large matrix it constructed. The major model used in GSBM is a two dynamic model, characterized by transient ZFS Δ<i>t</i> and static ZFS Δ<i>s</i> and their corresponding correlation time <i>τ</i>_ƒ and <i>τR</i>, while in SLA the model is only described by Δ<i>t</i> and <i>τ</i>_ƒ. A combined NMRD and ESR analysis is used to understand the details of ZFS interaction. Both models can reproduce experimental NMRD profiles and model parameters are similar; for ESR linewidths the model parameters are quite different. The fitting results indicate the NMRD profiles are less sensitive to the detail expression of ZFS correlation function. In order to interpret both NMRD and ESR experiments with identical parameters, a more complex ZFS interaction model should be developed.</p>

In cellular MRI, micrometer-sized iron oxide particles (MPIO) are a more sensitive contrast agent for tracking inflammatory-cell migration compared to ultra-small superparamagnetic iron oxide particles (USPIO). Inflammation, which promotes adverse tissue remodeling, is known to occur in the viable myocardium adjacent to the necrosed area after a myocardial infarction (MI). This study investigated the temporal relationship between inflammatory cell infiltration and cardiac function during tissue remodeling post-MI using MPIO-enhanced MRI. The MPIO were injected into 7 C57Bl/6 mice (MI+MPIO group) via intravenous administration. The MI was induced 7 days post-MPIO injection. As control groups, 7 mice (Sham+MPIO group) underwent sham-operated surgery without myocardial injury post-MPIO injection and another 6 mice (MI-MPIO group) underwent MI surgery without MPIO injection. MRIs performed post-MI showed a significant signal attenuation at the MI zone in the MI+MPIO group compared to the control groups. The findings suggested that the inflammatory cells containing MPIO infiltrated into the myocardial injury site. Cardiac function was also measured and correlated with the labeled-cell infiltration at the MI site. This study demonstrated a noninvasive technique for monitoring inflammatory cell migration using the MPIO contrast agent. This MPIO-enhanced MRI technique could provide additional insight concerning cardiac disease progression that would improve therapeutic treatment for MI patients.

Over the past several decades, gene therapy technologies have been developed for a diverse number of applications ranging from DNA-based vaccines to gene silencing with RNAi. While all are powerful tools, a common limitation for these technologies is the need for effective and safe delivery to target sites within the body. Such delivery vectors are necessary for retention of bioactivity and stability, while also providing a method of cellular and tissue uptake and distribution, which may require endosomal escape. Although, viral and lipid-based technologies have shown promise as nucleic acid delivery vectors, both have inherent issues such as cytoxicity, oncogenicity, and immunogenicity. Thus, the development of polymer-based non-viral vectors has been an area of great focus over the past decade. While many polymeric vectors have been developed for plasmid DNA (pDNA) delivery, very few have shown effective delivery of short interfering RNA (siRNA), a powerful tool for gene silencing via the RNA interference mechanism. Furthermore, very few prospective delivery vectors have shown versatility for the administration of siRNA through multiple routes of administration. The overall goal of this research was to develop a biocompatible non-viral delivery system for the delivery of plasmid DNA, siRNA, and contrast agents through the modification of the natural biopolymer chitosan. We have synthesized an imidazole modified chitosan (chitosan-IAA) by conjugation of imidazole acetic acid to chitosan. Extensive evaluation and characterization of the modified polymer demonstrates enhanced solubility and buffering capacity within the physiological and endosomal pHs, thus providing enhanced endosomal escape by exploiting the "proton sponge" effect. We have demonstrated effective in vitro gene expression and gene silencing with chitosan-IAA mediated delivery of pDNA and siRNA, respectively. Furthermore, we have demonstrated in vivo gene silencing by delivery of siRNA through both intranasal and intravenous routes of delivery with chitosan-IAA/siRNA nanocomplexes. We have also demonstrated delivery of contrast agents up to 45 nm in size through mucosal tissue following treatment with chitosan and no contrast agent modification in both human and animal tissue. In conclusion, we have successfully developed a versatile and highly effective delivery vector for both nucleic acids and contrast agents. / text

Ultrasound is one of the most widely used modalities in medical imaging because of its high cost-effectiveness, wide availability in hospitals, generation of real-time images, and use of nonionizing radiation. However, the image quality can be insufficient in some patients. Introducing a contrast agent (CA), which comprises a suspension of 2–6 mm-sized microbubbles, improves the image quality and thus the image analysis. At present, contrast-enhanced ultrasound is frequently used during standard clinical procedures such as kidney, liver, and cardiac (echocardiography) imaging. Multimodality and targeted imaging are future areas for ultrasound CAs. Multimodality imaging may improve diagnostics by simultaneously providing anatomical and functional information. Targeted imaging may allow for identification of particular diseases. The work within this thesis focused mainly on a novel multimodal polymer-shelled CA with the potential to be target specific. In Study I, the acoustic response was determined in a flow phantom by evaluating the contrast-to-tissue-ratio when using contrast sequences available in clinical ultrasound systems. This study showed that a high acoustic pressure is needed for optimal visualization of the polymer-shelled CA. In Study II, the in vivo performance of this CA was evaluated in a rat model, and the blood elimination time and subcellular distribution were determined. In Study III, the efficiency in endocardial border delineation was assessed in a pig model. The polymer-shelled CA had a significantly longer blood circulation time than the commercially available CA SonoVue, which is favorable for target-specific CA, in which a long circulation time increases the probability of target-specific binding. Transmission electron microscopic analysis of tissue sections from liver, kidney, spleen and lungs, obtained at different time points after CA injection showed that macrophages were responsible for the elimination of the polymer-shelled CA. A higher dose of the polymer-shelled CA was needed to obtain similar endocardial border delineation efficiency as that obtained using SonoVue. The results of Studies I–III demonstrate that the polymer-shelled CA has potential applicability in medical imaging. Current guidelines for contrast-enhanced echocardiography are limited to cases of suboptimal image quality or when there is a suspicion of structural abnormalities within the left ventricle. It may be hypothesized that the wider use of contrast-enhanced echocardiography may help to detect some diseases earlier. Study IV assessed the diagnostic outcomes after contrast administration in patients without indications for CA use. The myocardial wall motion score index and ejection fraction were evaluated by experienced and inexperienced readers, and a screening for left ventricular structural abnormalities was performed. More cases of wall motion and structural abnormalities were detected in the contrast-enhanced analysis. Intra- and interobserver variability was lower with the use of CAs. This study suggests that the more widespread use of CAs instead of the current selective approach may contribute to earlier detection of cardiovascular disease. / <p>QC 20150401</p>

Contrast agents are of great importance in clinical applications of Magnetic Resonance Imaging (MRI) to improve the contrast of internal body structures and to obtain tissue-specific image. However, current approved contrast agents still have limitations including low relaxivity, low specificity and uncontrolled blood circulation time, which motivated researchers to develop novel contrast agents with higher relaxivity, improved targeting abilities and optimal retention time. This thesis uses animal experimental data from Dr. Jenny J. Yang’s lab at the Department of Chemistry in Georgia State University to study effects of a class of newly designed protein-based MRI contrast agents (ProCAs). Models for the longitudinal data on MRI intensity are constructed to evaluate the efficiency of different MRI contrast agents. Statistically significant results suggest that ProCA1B14 has the great potential to be a tumor specific contrast agent and ProCA32 could be a promising MRI contrast agent for the liver imaging in clinical applications.

L’imagerie biomédicale est aujourd’hui un outil essentiel pour établir un diagnostic grâce à l’observation des tissus et des fluides biologiques. L’usage d’instruments à imagerie combinée avec des produits de contraste est la clé pour réussir à distinguer précisément un tissu ciblé via l’accumulation de produit de contraste dans le tissu. Les deux principaux appareils à imagerie utilisés sont le scanner à rayons X et l’imagerie à résonance magnétique (IRM). Ils sont fréquemment employés en complément de l’un et l’autre. Typiquement, de petites molécules iodées hydrophiles sont utilisées comme produit de contraste pour la radiographie à rayons X tandis que l’IRM implique des matériaux magnétiques tels que des nanoparticules d’oxyde de fer. Dans le cadre de ce projet doctoral, nous avons donc proposé deux nouveaux produits de contraste dont le premier visait à constituer une alternative aux produits iodés dont la rapide élimination et la toxicité rénale forment deux problèmes récurrents et un second produit, cette fois-ci bimodale, afin de faciliter les procédures d’imagerie bimodale. Pour le premier point, des nanoparticules de polymères iodés pour l’imagerie à rayons X ont été formulées et ce, par une technique de nanoprécipitation. Les paramètres de formulation ont été élucidés de telle sorte que les nanoparticules possédaient une distribution de taille adaptée pour l’administration par voie intraveineuse et une teneur en iode suffisante en iode pour contraster sous rayons X. Une étude in vivo a révélé le potentiel du produit de contraste à visualiser distinctement le foie et la rate et ce, tout en ne présentant pas les principaux problèmes des produits iodés commerciaux. La seconde étude a eu pour but de formuler des nano-véhicules lipidiques capables de générer un contraste pour l’imagerie à rayons X et l’IRM de par l’incorporation d’huile iodée et de nanoparticules d’oxyde de fer dans le coeur de nano-émulsions. Ceci avait pour objectif de fournir une plateforme nanoparticulaire bimodale pour réaliser efficacement et rapidement des procédures d’imagerie multimodale. Nous avons réussi à produire un efficace agent de contraste bimodal permettant d’observer distinctement le foie et les reins par IRM et le foie et la rate par imagerie à rayons X. La pharmacocinétique de la substance administrée a ainsi pu être mise en avant grâce à la bimodalité de l’agent. Employer l’IRM a permis de montrer qu’une fraction de la dose injectée était éliminée par voie rénale tandis que l’imagerie à rayons X a confirmé que les deux tissus, foie et rate,étaient passivement ciblés par l’agent de contraste. Ces deux études ont donc fournies de potentielles solutions pour répondre aux besoins en produits pour l’imagerie à rayons X et en formulations facilitant l’imagerie bimodale des tissus mous. / Biomedical imaging is nowadays an essential tool to establish a diagnosis by means of observation of tissues and biological fluids. Combination of imaging instrument with contrast enhancers is a key to obtain clear delineation of a desired tissue by accumulation of a contrast agent into this specific target. The two main imagers are the X-ray scanner and the magnetic resonance imaging (MRI).These imagers are frequently used in conjuncture. Typically, small hydrosoluble iodinated molecules are used as contrasting material for radiography whereas MRI involves magnetic materials like iron oxide nanoparticles. In this work, we proposed two novel contrast agents, the first one was aiming to form an alternative to iodinated contrast agents suffering from fast excretion and causing renal toxicity whereas the second one was aiming at providing bimodal contrasting ability to facilitate access to bimodal imaging procedure in clinics. In the first case, iodinated polymeric nanoparticles, serving for preclinical X-ray imaging were formulated by nanoprecipitation technique. Parameters of formulation were elucidated to provide nanoparticles with size distribution suitable for in vivo administration and high iodine content for contrast enhancement. In vivo study revealed the efficacy of our nanoparticles to clearly visualize liver and spleen and limiting current issues associated with marketed radiopaque contrast agents. The second work achieved was aiming at formulating bimodal lipids-based nanocarriers capable of yielding contrast enhancement for X-ray imaging and MRI by combining iodinated oil and iron oxide nanoparticles within a nano-emulsion core. This would provide bimodal nanoparticulate platform to carry out fast and efficient dual modal imaging procedures. In this context we succeeded to generate efficient dual modal contrast agent yielding clear visualization of liver and kidney by MRI and liver and spleen by X-ray imaging. Pharmacokinetic profile was so determined thanks to bimodal imaging. Using MRI allowed to show that kidneys eliminated a fraction of the dose whereas X-ray imaging confirmed that both tissues, liver and spleen, were passively targeted. These two studies proposed solutions limiting current issues of radiopaque contrast agents and novel formulations to facilitate bimodal imaging for soft tissues imaging.

L’Imagerie et la Spectroscopie par Résonance Magnétique du proton (IRM et ¹H SRM) sont des méthodes innovantes en toxicologie. Ces outils permettent l’évaluation de l’impact des xénobiotiques in vivo au niveau structural et métabolique respectivement. Dans cette perspective, les travaux de cette thèse ont été réalisés sur deux modèles murins : (i) des injections répétées de gadodiamide chez le rat entrainant une accumulation de gadolinium dans les noyaux profonds cérébelleux (NCP) ; (ii) une exposition à faible dose(20 μg/kg/jour) pendant la gestation et la lactation au bisphénol A (BPA) et à ses dérivés chlorés qui sont des perturbateurs endocriniens.L’étude des effets des injections répétées du gadodiamide a montré un rehaussement du signal des NCP sur des images pondérées T1 à 6 et 11 semaines post-injections. De manière inédite, il a été mis en évidence que le rehaussement du signal des NCP se maintient jusqu’à 1 an post-injections. Il a été également mesuré une augmentation prolongée de la concentration de créatine totale dans les NCP par la méthode de quantification ERETIC digital. Néanmoins, cette variation n’a pas été confirmée par les autres méthodes de quantification conventionnelles (jMRUI et LCModel). Une comparaison des méthodes de quantification en ¹H SRM (ERETIC digital, jMRUI et LCModel) a été réalisée afin de mettre en évidence l’influence de la correction de la ligne de base dans le traitement des spectres ¹H in vivo.Des perturbations précoces des dérivés chlorés du BPA ont été quantifiés chez les jeunes souris mâles et femelles exposées pendant la période périnatale : (i) des modifications de la composition lipidique hépatique, et cela préalablement à tout changement structural ; (ii) des altérations microstructurales et métaboliques au niveau de l’hippocampe. Une méthode de diffusion spectroscopique a été optimisée puisdes expériences in vivo ont été effectuées afin de caractériser ces anomalies de l’intégrité intracellulaire dans le cerveau des souris mâles. / Magnetic Resonance Imaging and Spectroscopy (MRI and ¹H MRS) are new methods in toxicology. These tools allow the assessment of the impact of xenobiotics at structural and metabolic levels respectively. In this perspective, this thesis presents two studies in animal models: (i) repeated administrations of linear gadolinium-based contrast agent (gadodiamide) in rat leading to a deposition of gadolinium in deep cerebellar nuclei (DCN); (ii) gestational and lactational exposure to bisphenol A (BPA) and its chlorinated derivatives at low dose (20 μg/kg/day) which are endocrine disruptors.The study of repeated injections of gadodiamide showed a hypersignal of DCN on T1-weighed images at 6and 11 weeks post-injections. In an unprecedented way, it was demonstrated that the hypersignal of DCN persisted for 1 year post-injections. A prolonged increase of total creatine concentration in DCN was also measured by the quantitation ERETIC digital method. Nevertheless, this variation was not confirmed by other conventional quantitation methods (jMRUI and LCModel). A comparison of quantitation methods in ¹H MRS (ERETIC digital, jMRUI and LCModel) was performed in order to elucidate the influence of baseline correction in the processing of in vivo ¹H spectra.Early disturbances caused by chlorinated derivatives of BPA were quantified in young male and female mice perinatally exposed: (i) modifications of hepatic lipid composition which precedes any structural change; (ii)microstructural and metabolic alterations in the hippocampus. A spectroscopic diffusion method was optimized, leading to in vivo experiments in order to characterize those abnormalities of intracellular integrity in the brain of male mice.